Project Grant R44CA297977
Award Date
5/7/25
Completion Date
4/30/27
Dollars Obligated
$1M
Federal Agency
National Cancer Institute
Awardee
5 Point App, Inc. (U9L9MKFL75D7)
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
미국 뉴욕
Similar Awards
This federal Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) will fund the adaptation and preliminary evaluation of the ENERGIZE-MBC intervention, a cognitive behavioral therapy program targeted at reducing fatigue among women with metastatic breast cancer treated with CDK4/6 inhibitors. The key products and services to be delivered under this $638,326 award include: 1) adapting an existing evidence-based cognitive behavioral therapy for fatigue...
The federal Project Grant award R01CA291888, with a total funding of $1,123,468, was provided by the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) to Duke University. The objective of this 5-year research project is to develop and test a novel hybrid-delivered cognitive behavioral intervention called STEP UP that combines symptom management coping skills training and activity coaching to improve physical disability, symptom severity, and physical activity levels in...
This federal Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower program) provides $173,997 to Duke University to develop and test a telehealth intervention called NITE2DAY+ for improving sleep disturbance and symptom management in hematologic cancer patients during and after inpatient treatment. The NITE2DAY+ intervention includes mindfulness meditations, sleep education videos, and tools to manage inpatient sleep disruptions. It will be delivered via...
This National Cancer Institute (NCI) Project Grant award under the Cancer Research Manpower program (CFDA 93.398) provides $224,968 to Wake Forest University Health Sciences to refine and test a cognitive behavioral therapy for insomnia (CBT-I) intervention for lung cancer survivors. The key objectives are to: 1) conduct stakeholder interviews and an advisory board to refine the CBT-I intervention for the unique needs of lung cancer survivors; 2) pilot test the refined CBT-I intervention with 30...
This Project Grant award from the National Cancer Institute under the Cancer Treatment Research program (CFDA 93.395) provides $594,734 to investigate the effects of a telehealth exercise program for rural cancer survivors experiencing cancer-related fatigue. The 5-year project will evaluate the efficacy of the "BFITBWell Telehealth Program" in a randomized controlled trial with 134 rural breast and prostate cancer survivors. The project also examines the impacts of impaired physical...
This $290,052 Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) aims to develop and evaluate a mobile-optimized personalized cancer support tool for young adult cancer survivors. The project, led by the Regents of the University of Michigan, will refine and test the "PERCS-YA" intervention to reduce worry and distress in young adults diagnosed with thyroid cancer, melanoma, and testicular cancer - three...
This federal Project Grant award, provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393), is funding a multi-site randomized controlled trial to evaluate the efficacy of a novel digital application called "DREAMLAND" in improving quality of life and psychological outcomes for patients with acute myeloid leukemia (AML) undergoing intensive chemotherapy. The total funding amount for this award is $591,372.00, with a project...
This Project Grant award for $712,508, provided by the National Center for Complementary and Integrative Health (NCCIH) under the Research and Training in Complementary and Integrative Health program (CFDA 93.213), aims to develop and evaluate the feasibility and acceptability of a tailored progressive muscle relaxation and walking intervention to reduce fatigue in adults with end-stage kidney disease (ESKD). The award will fund an early-phase clinical trial to assess this mind-body...
This federal Project Grant award of $621,732 from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) will fund a hybrid effectiveness-implementation trial to evaluate a proactive identification and digital mental health intervention approach to address unmet psychosocial needs of individuals living with likely incurable cancer. The key products and services to be delivered under this 5-year grant include: 1) comprehensively assessing the...
This federal Project Grant award of $707,367 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) will fund a randomized controlled trial to evaluate the efficacy of a novel mobile health (mHealth) smoking cessation intervention called GEMS. The intervention is designed to engage and support individuals who are ambivalent about quitting smoking, a hard-to-reach population that is often underserved by traditional evidence-based treatments. The key products and...